Drug Profile


Alternative Names: methionyl tRNA synthetase inhibitor; REP 8839

Latest Information Update: 02 Mar 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline
  • Developer Cardiovascular Systems
  • Class Antibacterials; Quinolines; Small molecules; Thiophenes
  • Mechanism of Action Methionine tRNA ligase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Suspended Skin and soft tissue infections; Staphylococcal infections

Most Recent Events

  • 02 Oct 2007 Data presented at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapeutics added to the Bacterial Infections antimicrobial activity section
  • 26 Jun 2007 Clinical data added to the adverse events section
  • 30 Oct 2006 Phase-I clinical trials in Staphylococcal infections in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top